Countagen develops quality control tools for gene editing methods to enable and accelerate research and development. Our first product is a simple-to-use consumable reagent kit that allows users to analyse gene editing efficiency and specificity. Our patent-pending technology offers a ‘plug-and-play’ solution that reduces the current time-consuming workflows from days to hours. It reliably counts and identifies gene editing events with high accuracy using only basic laboratory equipment. This makes our product simple to adopt into laboratory workflows and enables academic researchers, pharma and biotech companies to accelerate their gene editing research.
Location: Sweden, Stockholm
Employees: 1-10
Total raised: $1.1M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 28.06.2022 | Almi Inves... | almi.se |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 26.06.2022 | - | $1.1M | - | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 09.10.2023 | Who are Sweden’s Influential Trailblazers in the 2023 Medica... | Sweden’s medtech startup scene is flourishing, with a range of innovative companies emerging to addr... | eustartup.... |
| 10.06.2022 | 42 start-ups through to Catapult 2022-23 semifinals | We are excited to today announce the 42 promising start-ups that will go through to the semifinals o... | eithealth.... |